Skip to main content
Premium Trial:

Request an Annual Quote

Back to the Ivy

Eli Lilly’s senior VP for discovery and clinical research, William Chin, is heading to Harvard Medical School, reports the Wall Street Journal Health Blog. There, Chin will be the executive dean for research, a new position. According to the medical school dean, Chin will "conceptualize and develop new research initiatives, such as the therapeutics discovery initiative, envisioned as a focused and innovative effort to bring together the enormous expertise of our community in order to find effective new ways for transforming the world’s most vital biomedical research into therapies that can directly improve human health." Prior to joining Lilly, Chin was a professor at Harvard, where he also received his medical degree.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.